Cargando…

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells

How Epstein-Barr virus (EBV) affects the clinical outcome of EBV-positive diffuse large B-cell lymphoma (DLBCL) remains largely unknown. The viral oncogene LMP1 is at the crux of tumorigenesis and cell survival. Therefore, we examined the association between LMP1(high) cells drug resistance. We firs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Heejei, Ko, Young Hyeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421874/ https://www.ncbi.nlm.nih.gov/pubmed/28445949 http://dx.doi.org/10.18632/oncotarget.15600

Ejemplares similares

SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells
por: Yoon, Heejei, et al.
Publicado: (2020)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
por: Cheerathodi, Mujeeb, et al.
Publicado: (2021)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
por: Vrazo, Alexandra C., et al.
Publicado: (2012)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
por: Rahman, Rifat, et al.
Publicado: (2019)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells
por: Salahuddin, Sadia, et al.
Publicado: (2019)

Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
por: Hau, Pok Man, et al.
Publicado: (2011)

Detection of Epstein-Barr Virus by PCR and Expression of LMP1, p53, CD44 in Gastric Cancer
por: Lee, Myung Ah, et al.
Publicado: (2004)

Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation
por: Ding, Ran-ran, et al.
Publicado: (2019)

Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells
por: Nkosi, Dingani, et al.
Publicado: (2020)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
por: Edwards, Rachel Hood, et al.
Publicado: (2015)

The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019)

Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition
por: Lo, Angela KF, et al.
Publicado: (2010)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
por: Huo, Haifeng, et al.
Publicado: (2019)

Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation
por: Mitra, Bidisha, et al.
Publicado: (2023)

Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ
por: Singh, Deo R., et al.
Publicado: (2023)

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
por: Smatti, Maria K., et al.
Publicado: (2018)

CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development
por: Huang, Bonnie, et al.
Publicado: (2016)

LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus–Transformed B Cells
por: Yun, Sun-mi, et al.
Publicado: (2019)

Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein‐Barr virus–positive gastric cancer
por: Li, Wenzhe, et al.
Publicado: (2021)

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
por: Kim, Seok-Jin, et al.
Publicado: (2019)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals
por: Yoshimori, Mayumi, et al.
Publicado: (2014)

Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells
por: Xu, Yang, et al.
Publicado: (2013)

Colocalization of Interferon Regulatory Factor 7 (IRF7) with Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
por: Kim, In-Wook, et al.
Publicado: (2006)

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation
por: Greenfeld, Hannah, et al.
Publicado: (2015)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
por: Banko, Ana, et al.
Publicado: (2021)

Loss of P16 Protein Expression and Its Association with Epstein-Barr Virus LMP-1 Expression in Hodgkin's Lymphoma
por: Irshaid, Fawzi, et al.
Publicado: (2013)

Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs
por: Yajima, Misako, et al.
Publicado: (2019)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
por: Khenchouche, Abdelhalim, et al.
Publicado: (2023)

Distribution of Epstein–Barr Virus LMP1 Variants in Patients with Infectious Mononucleosis and Association with Selected Biochemical and Hematological Parameters
por: Zidovec-Lepej, Snjezana, et al.
Publicado: (2023)

Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma
por: Murata, Takayuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tnpl25vn9e9ccpm79g2d287f6e